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cparental history (PH) of coronary heart disease
(CHD) is consistently associated with a higher
risk of the development of CHD in several
tudies (1–9). It is generally accepted that this associa-
ion is explained by a combination of predominantly
nown risk factors and genetic variants (10). Al-
hough many studies show that risk factors and ge-
etic polymorphisms are significantly associated with
yocardial infarction (MI), these studies fail to show
ow these associations may explain the relationship
etween PH and the risk of MI (11,12). Some previ-
us studies established the independence of PH from
ommon vascular risk factors (7); however, there are
ew large international studies that can establish the
ndependence of PH from comprehensive measure-
ents of behavioral, biological, psychosocial, and
enetic risk factors, as reported in the INTERHEART
tudy.
The aims of this analysis were: 1) to examine whether
he risk associated with a score of PH of MI (increasing
ith the number of affected parents and prematurity of rH) is independent of behavioral, biological, psychoso-
ial, and genetic factors; and 2) to evaluate whether these
ndings are consistent across sex, age groups, socioeco-
omic groups, and world regions.
See page 628
ethods
articipants. INTERHEART was a multinational
ase-control study that enrolled 15,152 cases present-
ng with a first MI and 14,820 controls matched for
ge and sex between February 1999 and March 2003.
etails of selection criteria were reported previously
13). In the principal analysis of the INTERHEART
tudy, cases and controls were excluded if they did not
eet inclusion criteria (e.g., previous CHD) or had
nsufficient data, leaving 12,461 cases and 14,637
ontrols (13). For the present analysis, participants
ere also excluded if data on PH of cardiovascular
isease (CVD) were incomplete. Therefore, 12,149
ases and 14,467 controls were included in the cur-
ent analysis.
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Parental History and Myocardial Infarction February 1, 2011:619–627linical variables. Data on demographic factors, socio-
conomic status, biological risk factors (hypertension, dia-
etes, lipids, waist-to-hip ratio), behavioral risk factors (to-
acco use, alcohol use, physical activity, fruit and vegetable
ntake), and psychosocial risk factors (depression, perma-
ent stress, financial stress, stressful events, and perceived
ocus of control) (14) were obtained for all participants.
sychosocial risk factors were combined into a score based
n categories of each of the factors listed previously, and
his was detailed in a previous paper (14).
Hereafter we refer to the 9 risk factors (abnormal lipids,
moking, hypertension, diabetes, abdominal obesity, psychoso-
ial factors, physical activity, fruit and vegetable consumption,
nd alcohol consumption) as the INTERHEART risk factors.
he presence or absence of a history of MI in the mother
nd/or father was recorded for each case and control. Par-
icipants also reported whether MI occurred before the age
f 50 years in each parent.
Details of blood sampling, storage, transportation, and
nalyses were published previously (15). The protocol was
pproved by the ethics committee at each of the participat-
ng centers, and all participants provided informed consent.
Genetic analysis was performed in 8,795 (32%) partici-
ants enrolled in INTERHEART study. This included partic-
pants from 5 ethnic groups (Arab, European, Iranian, Ne-
alese, and South Asian) who were genotyped using a panel of
,536 single nucleotide polymorphisms (SNPs) from 103
enes that were chosen based on previous knowledge suggest-
ng a relationship with MI or MI risk factors (16). Cases and
ontrols were matched by ethnicity in addition to age (5
ears) and sex. To develop a genotype score, the relationship of
ach of the 1,536 SNPs was examined in models with MI as
he dependent variable including age, sex, and ethnicity. The
op 20 most significant SNPs (p 0.007) (rs3798221,
s2113485, rs6980952, rs11679259, rs2020942, rs7015547,
s4520, rs11615630, rs5070, rs9364559, rs2972162,
s1293309, rs854548, rs1298295, rs854542, rs4073054,
s3760627, rs2239375, rs2645424, rs3813667) were tested in
multiple logistic regression model. From this model, 9 SNPs
rs7412, rs699, rs3798221, rs4420638, rs6511720,
s2972162, rs730365, rs4520, rs11679259) from 8 genes
APOE, AGT, LPA, LDLR, PPARG, PON2, APOC3,
NSIG2) were found to remain significant (p 0.05). The
inor allele frequencies of these SNPs for each ethnic group
re described in the Online Appendix. A test for Hardy-Weinberg
quilibrium criteria was performed. All SNPs were in Hardy- aeinberg equilibrium in each ethnicity. The directions of associa-
ions were the same for the majority of the 9 SNPs except for
s6511720, rs7412, and rs4420638 in Nepalese compared with
ther ethnic groups and rs6511720 in South Asians compared
ith other ethnic groups. The 9 SNPS were used to calculate the
enotype score (the number of risk alleles that an individual pos-
esses). For each of the 9 significant SNPs, 0 points were allocated
f no risk alleles were carried by an individual, 1 point if 1 risk
llele, and 2 points if 2 risk alleles. We defined an allele as protec-
ive according to what was derived as protective in the overall
ataset, and we did not use ethnicity-specific scores. Thus, the
otential genotype score for each subject ranged from 0 to 18.
he mean scores for controls and cases (11.9 and 12.2, respec-
ively) are9 because in several cases, the major allele is the risk
llele. The methodology that we used to create this genotype score
as similar to that described by a number of groups seeking to
ggregate genetic information (17–19). A total of 3,372 cases and
,032 controls had complete clinical and genetic data, and the
haracteristics of those genotyped compared with those not geno-
yped are included in the Online Appendix.
tatistical methods. Multiple logistic regression models
ere used to quantify the association between the risk of
I and PH of MI. Age, sex, and region were forced in all
odels. In more complex models, we adjusted for the 9
NTERHEART risk factors. We tested for significant inter-
ctions in risks among groups stratified by sex, age of par-
icipant (men 55 years and younger and women 65 years
nd younger), education, and country-specific economic
evel based on World Bank classifications for the relevant
eriod 1999 to 2003 (20). We also examined risk stratified
y overall cardiovascular risk (calculated using a risk equa-
ion derived from the Framingham cohort [21]), region,
nd ethnicity. In the subset of participants who were geno-
yped, the genotype score was included in multiple logistic
egression models adjusted for age, sex, region, and the 9
NTERHEART risk factors.
We scored PH as follows: Those with no PH were desig-
ated as the reference group. The groups in order of least to
ost severe were: 1) history of disease in 1 parent 50 years of
ge or older; 2) disease in 1 parent younger than 50 years of
ge; 3) disease in both parents 50 years of age or older; 4) dis-
ase in 1 parent 50 years of age or older and 1 parent younger
han 50 years of age; and 5) disease in both parents younger
han 50 years of age. We compared risk factor levels between
roups using t tests. All statistical tests were 2 sided. Statistical
nalyses and graphics were produced with the SAS system
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-Plus version 6 (TIBSO Software Inc., Palo Alto, California).
esults
he distribution of risk factors between cases and controls
as reported previously and is summarized in Table 1 (13).
enotype score was higher in cases compared with con-
rols, and the distribution of this score is reported in Table
. The prevalence of PH of MI in either parent was 18.1%
f cases and 12.0% of controls, and the prevalence of PH
f MI in both parents was 2.1% of cases and 0.9% of con-
rols. PH of MI in the mother was reported by 7.5% of
ases and 4.9% of controls and PH of MI in the father was
eported by 12.7% of cases and 8.1% of controls.
Table 1 Characteristics of Cases and ControlsFrom the INTERHEART Study
Characteristics Controls Cases
No. of individuals 14,637 12,461
Female 3,786 (26) 3,005 (24)
Age, yrs 56.9 12.2 58.1 12.2
Smoking
Current 26.8 45.2
Current or past 48.1 65.2
Diabetes 7.5 18.5
Hypertension 21.9 39.0
Daily intake of fruits and
vegetables
42.4 35.8
Exercise daily 19.3 14.3
Alcohol intake 24.5 24.0
Body mass index, kg/m2 25.8 4.2 26.1 4.2
Waist-to-hip ratio 0.91 0.08 0.93 0.08
Apolipoprotein B, g/l 0.90 (0.74–1.07) 0.95 (0.78–1.13)
Apolipoprotein A-I, g/l 1.19 (1.03–1.37) 1.10 (0.96–1.36)
Apolipoprotein B/apolipoprotein
A-I ratio
0.75 (0.60–0.93) 0.87 (0.70–1.05)
alues are n, n (%), mean  SD, %, or median (interquartile range).
Table 2 Genotype Score Distribution in Subsampleof Participants From the INTERHEART Study
Controls Cases p Value
No. of individuals 4,043 3,372
Genotype score
Mean (SD) 11.897 (1.756) 12.237 (1.697) 0.0001
Median 12 12
5, % 0 0
5–10, % 21.0 15.2 0.0001
11–13, % 61.3 62.0 0.486
13, % 17.7 22.8 0.0001Mssociation of PH of MI with MI. The odds ratio
OR) of MI associated with a PH of MI in either parent
age, sex, and region adjusted) was 1.81 (95% confidence
nterval [CI]: 1.69 to 1.94). Compared with those with no
H, persons with a PH of MI at an age of 50 years or older
n 1 parent had an OR for MI of 1.67 (95% CI: 1.55 to
.81), persons with a PH of MI in 1 parent younger than
0 years had an OR for MI of 2.36 (95% CI: 1.89 to
.95), persons with both parents with an MI 50 years or
lder had an OR for MI of 2.90 (95% CI: 2.30 to 3.66),
ersons with both parents with an MI but 1 younger than
0 years of age had an OR for MI of 3.26 (95% CI: 1.72 to
.18), and persons with both parents with a premature MI
ad an OR for MI of 6.56 (95% CI: 1.39 to 30.95). This
raded relationship with MI risk remained after adjusting
or the 9 INTERHEART risk factors (Fig. 1). There was
mprovement in model fit with the addition of PH of MI
area under the curve of the model with age, sex, region,
nd previously described 9 risk factors was 72.9%, and with
he addition of PH score, it was 73.2%; p  0.0001). The
opulation-attributable risks for a PH of MI (including the
ifferent grades of family history) were 12.4% (95% CI:
1.1% to 13.9% after adjusting for age and sex and 10.1%
95% CI: 8.5% to 12.1%) after additionally adjusting for
he 9 previously mentioned risk factors.
ATERNAL VERSUS PATERNAL HISTORY OFMI ASSOCIATED
ITH MI. Both maternal and paternal histories of MI
ere associated with increased MI risk. There were no
tatistical differences in the risks associated with pater-
al and maternal history of MI. The OR for MI asso-
iated with a paternal history of MI was 1.84 (95% CI:
.69 to 2.0), and for a maternal history of MI, it was
.72 (95% CI: 1.56 to 1.91), and they were not signifi-
antly different (p  0.692 for heterogeneity).
ONTRIBUTION OF BEHAVIORAL, BIOLOGICAL, AND
SYCHOSOCIAL FACTORS TO THE ASSOCIATION
ETWEEN PH OF MI AND MI. The OR of MI associated
ith a PH of MI in either parent was 1.81 after age,
ex, and region adjustment and remained unchanged at
.84 (95% CI: 1.70 to 1.98) after adding behavioral
actors, 1.80 (95% CI: 1.64 to 1.97) after adding bio-
ogical factors, and 1.74 (95% CI: 1.58 to 1.92) after
dding psychosocial factors (Table 4). These findings
uggest that the 9 INTERHEART risk factors only
xplain to a modest degree the relationship of PH of
I with risk of MI.
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Parental History and Myocardial Infarction February 1, 2011:619–627ONSISTENCY OF FINDINGS ACROSS SUBGROUPS AND
EGIONS. The age-, sex-, and region-adjusted OR as-
ociated with a PH of MI was higher for younger indi-
iduals (men 55 years of age and younger and women
5 years of age and younger) compared with older indi-
iduals. The OR was 2.01 (95% CI: 1.84 to 2.20) for
ounger ages and 1.54 (95% CI: 1.38 to 1.72) for older
ges (p  0.0002 for heterogeneity). However, after
djusting for the 9 INTERHEART risk factors, the
R for younger people was 1.84 (95% CI: 1.62 to
.08) and for older people 1.60 (95% CI: 1.38 to 1.86),
nd the difference in risks became insignificant (p 
Table 3 Characteristics of Case and Control Participants Wi
Control
Characteristics
No PH of MI
(n  12,714)
With P
(n  1
Body mass index, kg/m2 26.3 26
Waist-to-hip ratio 0.90 0
Blood pressure, mm Hg
Systolic 129 131
Diastolic 80 80
Cholesterol, mmol/l
Total 5.28 5
LDL 3.25 3
Triglycerides 1.92 2
HDL 1.17 1
Apo B 0.93 0
Apo A-I 1.27 1
Apo B/Apo A-I ratio 0.77 0
HbA1c 5.85 5
Smoking
Current or past 40.6 45
Current 16.8 15
Past 17.2 22
Diabetes 6.6 8
Hypertension 20.2 24
Alcohol consumption 18.7 21
Physical activity 20.3 22
Consume both fruits and vegetables daily 48.0 54
Depression 18.8 21
Stress
Permanent 4.1 5
Several periods 17.7 19
Severe financial stress 9.6 7
Moderate financial stress 34.9 32
2 stressful events 13.4 13
Least control over life 33.1 31
alues are listed as mean or %.
Apo  apolipoprotein; HbA1c  glycosylated hemoglobin; HDL  high-density lipoprotein;.154 for heterogeneity), suggesting that risk factor dif- ferences explained the initial heterogeneity observed.
he results were consistent in fully adjusted models
cross geographic regions, ethnic groups, world eco-
omic regions (based on World Bank economic classifi-
ation), socioeconomic groups in both sexes and all age
roups and when stratified by cardiovascular risk (Fra-
ingham risk score) (Tables 5 and 6).
ONTRIBUTION OF GENETIC RISK FACTORS TO ASSOCIATION
ETWEEN PH OF MI AND MI RISK. In the subset of 7,415
ith complete genetic and clinical data, the OR associ-
ted with a PH of MI was unchanged after adjusting
d Without a PH of MI (Adjusted for Age, Sex, and Region)
Cases
I
p Value
No PH of MI
(n  9,935)
With PH of MI
(n  2,214) p Value
0.0001 26.8 27.3 0.0001
0.0189 0.93 0.93 0.8382
0.0005 122 121 0.0190
0.0017 74 74 0.0531
0.0001 5.43 5.50 0.0430
0.0001 3.49 3.52 0.2825
0.0087 1.96 2.04 0.0246
0.0877 1.06 1.07 0.3625
0.0001 1.00 1.01 0.0811
0.0006 1.15 1.16 0.3367
0.0003 0.91 0.91 0.3926
0.7520 6.16 6.12 0.2979
0.0010 58.6 62.2 0.0103
0.2138 34.9 35.4 0.6772
0.0001 14.7 16.8 0.0103
0.0248 29.8 22.2 0.0227
0.0001 41.6 45.3 0.0042
0.0180 14.0 15.7 0.0323
0.0199 13.6 14.4 0.3272
0.0001 38.3 43.6 0.0001
0.0041 26.2 29.2 0.0124
0.0242 7.2 10.5 0.0001
0.1459 21.6 21.0 0.5500
0.0085 13.9 13.4 0.5271
0.0717 37.1 34.8 0.0558
0.9353 17.6 20.2 0.0056
0.2924 16.7 19.2 0.0133
low-density lipoprotein; MI  myocardial infarction; PH  parental history.th an
s
H of M
,753)
.7
.89
.57
.49
.02
.19
.98
.30
.80
.86
.2
.7
.5
.1
.6
.2
.9
.3
.8
.2
.2
.8
.6
.4
.7or genotype score (Table 4).
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February 1, 2011:619–627 Parental History and Myocardial InfarctionISK FACTORS IN THOSE WITH AND WITHOUT A PH OF
I. Risk factors were compared in participants reporting a
H of MI in at least 1 parent and those not reporting a
H of MI. Those reporting a PH of MI were younger
55.0 years vs. 57.9 years; p  0.0001). Biological and
sychosocial risk factors were generally more adverse in
hose with a PH of MI. Behaviors, however, were gener-
lly better in those with a PH of MI. The patterns of dif-
Figure 1 Relationship of Parental History of Myocardial Infar
The 9 risk factors in the models are hypertension, diabetes, lipids, waist-to-hip
psychosocial risk factors. One parent older, disease in 1 parent, diagnosed wh
when younger than 50 years of age. Two parents older, disease in both parent
both parents, at least 1 parent diagnosed when younger than 50 years of age.
Table 4 Risk of MI Associated With PH of MI and Adjustmenand Genetic Risk Factors
Odds Ratio Mother
Unadjusted 1.61 (1.45–
Adjusted for age, sex, region 1.73 (1.56–
Adjusted for age, sex, region, behavioral RFs 1.74 (1.55–
Adjusted for age, sex, region, behavioral and biological RFs 1.63 (1.42–
Adjusted for age, sex, region, 9 RFs 1.54 (1.33–
Adjusted for age, sex, region, 9 RFs, genotype score* 1.57 (1.34–alues are odds ratio (95% confidence interval). *Analysis in 3,269 cases and 4,032 controls. All
RF  risk factor; other abbreviations as in Table 3.erences in risk factors between those with and without a
H of MI are similar for both cases and controls (Table 3).
Genotype score was calculated for 3,372 cases and
,043 controls. Although the genotype score was higher
n cases compared with controls (Table 2), it was not
igher in those with a PH versus those without a PH
f MI. The mean genotype score was 11.90 (SD 
.75) in controls with no PH of MI, 11.84 (SD 
and Risk of Myocardial Infarction
tobacco use, alcohol use, physical activity, fruit and vegetable intake, and
er than 50 years of age. One parent younger, disease in 1 parent, diagnosed
nosed when older than 50 years of age. Two parents younger, disease in
no parental history; RF  risk factor.
Behavioral, Biological, Psychosocial,
PH of MI
Father Mother or Father Mother and Father
1.65 (1.53–1.79) 1.62 (1.51–1.73) 2.43 (1.96–3.01)
1.84 (1.69–2.00) 1.81 (1.69–1.94) 2.65 (2.14–3.29)
1.85 (1.69–2.02) 1.84 (1.70–1.98) 2.52 (2.00–3.17)
1.86 (1.67–2.08) 1.80 (1.64–1.97) 2.37 (1.77–3.15)
1.85 (1.65–2.07) 1.74 (1.58–1.92) 2.26 (1.68–3.06)
1.45 (1.25–1.68) 1.50 (1.32–1.70) 2.28 (1.64–3.17)ction
ratio,
en old
s, diag
Nil t for
1.78)
1.91)
1.94)
1.86)
1.76)
1.86)other models include 14,467 controls and 12,149 cases.
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Parental History and Myocardial Infarction February 1, 2011:619–627.81) in controls with a PH of MI, 12.26 (SD  1.71)
n cases with no PH of MI, and 12.14 (SD  1.68) in
ases with a PH of MI.
iscussion
he findings of this study indicate that a PH of MI scored
Table 5
Risk of MI Associated With PH of MI
and Comparisons Within Major Subgroups:
Analysis of 14,467 Controls and 12,149 Cases
PH of MI Adjusted
for Age, Sex, Region
PH of MI Adjusted
for 9 Risk Factors
Overall 1.81 (1.69–1.94) 1.74 (1.58–1.92)
Sex
Women 1.62 (1.41–1.86) 1.65 (1.36–2.00)
Men 1.88 (1.73–2.04) 1.78 (1.59–1.98)
p value for heterogeneity 0.0694 0.5078
Age
Younger (men 55 yrs,
women 65 yrs)
2.01 (1.84–2.20) 1.84 (1.63–2.08)
Older (men 55 yrs,
women 65 yrs)
1.54 (1.38–1.72) 1.60 (1.38–1.86)
p value for heterogeneity 0.0002 0.1539
Highest level of education
completed
Trade/college/university 1.73 (1.56–1.93) 1.75 (1.51–2.02)
9–12 yrs of education 2.04 (1.79–2.33) 1.97 (1.64–2.37)
8 yrs of education 2.00 (1.76–2.28) 1.69 (1.42–2.01)
p value for heterogeneity 0.098 0.4415
Household income
Low (lowest 2 quintiles
of income)
1.88 (1.64–2.15) 1.76 (1.55–2.00)
Middle (middle quintile) 1.56 (1.26–1.93) 1.78 (1.52–2.09)
High (upper 2 quintiles) 1.73 (1.47–2.06) 1.76 (1.55–2.00)
p value for heterogeneity 0.3380 0.4430
Economic development of
country*
Low income 1.69 (1.40–2.04) 1.60 (1.23–2.07)
Middle income 1.98 (1.80–2.19) 1.88 (1.66–2.13)
High income 1.60 (1.41–1.81) 1.53 (1.27–1.86)
p value for heterogeneity 0.0199 0.1699
Cardiovascular risk
Low Framingham risk
(1st tertile)
2.06 (1.79–2.37) 1.96 (1.66–2.30)
Medium Framingham risk
(2nd tertile)
1.68 (1.47–1.92) 1.57 (1.35–1.83)
High Framingham risk
(3rd tertile)
1.82 (1.55–2.13) 1.75 (1.46–2.10)
p value for heterogeneity 0.1210 0.1566
alues are odds ratio (95% confidence interval) unless otherwise indicated. PH of MI is
elf-reported history of MI in mother or father. *Economic development of each country was
ased on World Bank classifications for the relevant period 1999 to 2003 (http://web-
orldbank.org).
Abbreviations as in Table 3.n clinical history is an independent predictor of future rI. The strength of this association is minimally attenu-
ted in models adjusted for age, sex, region, and the 9 IN-
ERHEART risk factors. The strength of association be-
ween a PH of MI and MI risk is also consistent across
eographic regions, age, sex, and socioeconomic subgroups.
ifferences in crude measures of strength of association
ORs) by world economic region, geographic region, or
thnicity is likely due to risk factor differences across re-
ions as the difference in ORs became nonsignificant after
djusting for the previously mentioned 9 risk factors.
Of note is that our findings indicate that the strength of
ssociation of parental history of MI and MI risk is similar
cross different risk groups. Household income is a measure
f socioeconomic status within a country, and our results
ndicate that the risk associated with a PH of MI is similar
cross groups of differing socioeconomic status within a
ountry. Although we note that previous studies indicate
he strength of association of family history with cardiovas-
ular outcomes is greater in low-risk groups (22), our find-
ngs indicate that the associations are not significantly dif-
erent in groups of low, medium, and high risk (as defined
y tertiles of Framingham risk score). Thus, the simple
elf-report measure of a PH of MI confers a near doubling
f MI risk regardless of background risk factors, country,
nd age or whether the history was from the mother or
ather.
The reason for the association between a PH of MI is
ften attributed to a combination of shared risk factors
nd genetics (12). Consistent with this hypothesis is the
arginal attenuation of the effect of PH on the risk of
I that we observed in this study, which has also been
bserved in other studies (8,9). Consistent with this,
ther studies find that more detailed information on
amily history (e.g., considering the number of relatives
ith coronary disease, degree of relationship, lineage,
nd age at diagnosis) also adds to risk prediction based
n risk factors and a single metric of family history
23,24). This raises the question of what PH is a mea-
ure of. Are there other factors that are unmeasured that
ould explain the relationship between PH of MI and
isk of MI? Could other factors shared in families be the
ulprit? For example, early life exposures such as early
ife stress or early life nutrition may affect early develop-
ent of atherosclerosis. Such influences may be trans-
enerational and hence could be causing increased MI
isk (25). Home environmental factors such as exposure
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February 1, 2011:619–627 Parental History and Myocardial Infarctiono similar social factors or indoor air pollution may also
ontribute. Unmeasured genetic factors offer a strong
otential explanation for the association between family
istory and MI. Although we have attempted to examine
he contribution of some genetic factors through a geno-
ype score of selected SNPs derived from a large panel of
enotype variants known or hypothesized to be related
o MI or its risk factors, the list of genotype variants
ncluding those from recent genome-wide associations
tudies related to MI is continually growing (26,27).
he genotype score here only represents a small percent-
ge of the possible genotype variants, and all but 1 of the
NPs (the one near AGT) used to derive the genotype
core are in or near candidate genes that have been im-
licated in cholesterol metabolism. In this context, our
enotype risk score probably had very limited ability to
redict risk of MI independent of serum lipids levels. A
igher mean genotype score was seen in cases compared
ith controls. It would be expected that the genotype
Table 6 Risk of MI Associated With PH of MI by Geographic
Geographic regions
Western Europe (656 cases, 766 controls)
Central and Eastern Europe (1,689 cases, 1,918 controls)
Middle East (1,614 cases, 1,778 controls)
Africa (561 cases, 783 controls)
South Asia (1,676 cases, 2,200 controls)
China and Hong Kong (3,014 cases, 3,054 controls)
Southeast Asia and Japan (941 cases, 1,198 controls)
Australia and New Zealand (588 cases, 677 controls)
South America and Mexico (1,184 cases, 1,847 controls)
North America (283 cases, 333 controls)
p value for heterogeneity
Ethnic groups
European (3,254 cases, 3,689 controls)
Chinese (3,114 cases, 3,165 controls)
South Asian (2,100 cases, 2,565 controls)
Other Asian (850 cases, 1,072 controls)
Arab (1,292 cases, 1,476 controls)
Latin American (1,095 cases, 1,794 controls)
Black African (148 cases, 362 controls)
Colored African (304 cases, 339 controls)*
Other (49 cases, 92 controls)
p value for heterogeneity
alues are odds ratio (95% confidence interval) unless otherwise specified. *The colored Af
ncestry descending from the first South African nations, the Khoi and San people, as well
Abbreviations as in Table 3.core would also be higher in those with a PH compared aith those without, if these common genotype variants
ontributed substantially to the relationship between PH
nd MI risk. However, this was not seen in either cases
r controls. As currently known loci still only explain a
mall proportion of the variance of risk of CHD, the
ower to detect differences with any genotype score is
ikely to be very poor. It is very likely that many genetic
actors are yet to be identified, and an important sup-
orting argument for this is that twin studies in which
hared environmental risk factors are largely accounted
or show a clear increase in risk of CHD when the twin
as CHD, which is greater among monozygotic twins
nd thus argues strongly for a genetic component to the
xplanation for the association observed between family
istory of MI and MI risk (28).
In our study, individuals with a PH had more adverse
evels of most biological risk factors and psychosocial risk
actors. However, behavioral risk factors (current and past
moking, fruit and vegetable intake, physical activity, and
on and Ethnicity
PH of MI Adjusted for
Age, Sex, Region
PH of MI Adjusted for
9 Risk Factors
1.29 (1.02–1.65) 1.36 (0.97–1.89)
1.72 (1.44–2.05) 2.00 (1.58–2.53)
1.87 (1.55–2.26) 1.53 (1.21–1.93)
2.65 (1.96–3.60) 2.09 (1.40–3.12)
1.63 (1.36–1.95) 1.54 (1.20–1.99)
1.93 (1.42–2.64) 1.82 (1.28–2.60)
2.44 (1.85–3.22) 1.95 (1.38–2.77)
1.93 (1.54–2.43) 2.18 (1.44–3.29)
2.02 (1.68–2.44) 1.87 (1.46–2.39)
1.24 (0.90–1.71) 1.24 (0.62–2.51)
0.0015 0.4184
1.52 (1.36–1.69) 1.76 (1.50–2.07)
1.94 (1.46–2.58) 1.71 (1.23–2.38)
1.67 (1.42–1.97) 1.47 (1.17–1.84)
2.37 (1.77–3.17) 1.74 (1.21–2.52)
2.08 (1.67–2.56) 1.76 (1.37–2.27)
2.08 (1.72–2.52) 2.01 (1.56–2.60)
7.23 (1.89–27.71) 10.95 (1.83–65.72)
1.94 (1.33–2.83) 1.75 (1.08–2.85)
1.65 (0.73–3.69) 6.65 (1.50–29.54)
0.0045 0.1767
oup in this study is predominantly from South Africa and represents a group of mixed race
pean, African, and Malaysian people.Regi
rican grlcohol consumption) were more favorable in those with a
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ith a PH could be because individuals in this study may
ave already changed their lifestyle due to a greater aware-
ess of risk, although information bias may also be a possi-
le explanation. However, the higher levels of modifiable
isk factors including lipids, obesity, and diabetes indicate
hat clinicians should aggressively manage risk factors in
hose with a PH of CHD (29).
The strengths of this study are its large international
overage in ethnically and socioeconomically diverse popu-
ations, the large number of cases of MI, and the compre-
ensive measurement of risk factors including genetic fac-
ors. It thus has wider population implications compared
ith previous studies and is able to establish the indepen-
ence of the measure of a PH of MI from a long list of po-
ential confounders. Further research is required to examine
hether other determinants, genetic, early life determi-
ants, or common family level influences (e.g., environ-
ental exposures) may explain the relationship between a
H of MI and MI risk.
tudy limitations. First, only data on PH were collected
n this study; data on a history of MI in siblings or other
elatives were not collected. Second, we had limited mea-
ures of SNPs in a limited number of individuals from our
tudy population. We did not have adequate numbers of
ndividuals to derive our genotype score in a training set
eparate from the evaluation set, and this raises the potential
f overfitting. Third, the case-control design of this study
aises the possibility of recall biases influencing our results.
tudies have shown that although specificity of self-reported
amily history is high (90% to 100%), the sensitivity of self-
eported family history can be low (50% to 70%) (30). This
naccuracy could mean our estimations are an underestimation
f the risk associated with family history (31). However, stud-
es examining the risk of MI associated with a validated PH of
VD (MI/angina/stroke/other vascular disease) report results
imilar to ours (Lloyd-Jones et al. [9] document an age-ad-
usted OR for the risk of CVD associated with a validated PH
f nonpremature CVD of 1.9 (95% CI: 1.2 to 3.0) in men
nd 1.6 (95% CI: 0.9 to 2.9) in women. In comparison in this
tudy, the age-adjusted OR for risk of MI associated with a
H of MI is 1.88 (95% CI: 1.73 to 2.04) in men and 1.62
95% CI: 1.41 to 1.86) in women.
We think that differential recall bias is unlikely be-
ween cases and controls because a PH of MI is likely to se an enduring memory and recalled equally by cases
nd controls.
onclusions
H of MI is an easy-to-measure risk factor that is signifi-
antly associated with a risk of MI independent of the 9
stablished risk factors as well as some common genetic
actors, and this relationship is consistent across all world
egions, income, age, and sex groups studied in the
NTERHEART study. Further, clinical grading of risk
etermined by self-reported information from a patient on
he age at onset of disease in parents and whether 1 or both
arents are affected provides a simple but robust assessment
f their risk in this population of patients independent of
ther measured risk factors.
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